Alawami, M, Kenedi, C, Cicovic, A, Muir, A (2012). Echocardiography in the prevention of clozapine induced cardiomyopathy. European Journal of Heart Failure Supplements 11 (Suppl. 1): S27.
Conley, RR (1998). Optimizing treatment with clozapine. Journal of Clinical Psychiatry 59 (Suppl. 3): 44–48.
Estefanos, M, Swift, R, Bernhardt, LL (2013). Clozapine and cardiomyopathy: a case report. CNS Spectrums 18, 334–335.
Floreani, J, Bastiampillai, T (2008). Successful re-challenge with clozapine following development of clozapine-induced cardiomyopathy. The Australian and New Zealand Journal of Psychiatry 42, 747–748.
Krakowski, MI, Czobor, P, Citrome, L, Bark, N, Cooper, TB (2006). Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder. Archives of General Psychiatry 63, 622–629.
Meltzer, HY, Alphs, L, Green, AI, Altamura, AC, Anand, R, Bertoldi, A, Bourgeois, M, Chouinard, G, Islam, MZ, Kane, J, Krishnan, R, Lindenmayer, JP, Potkin, S (2003). Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Archives of General Psychiatry 60, 82–91.
Merrill, DB, Dec, GW, Goff, DC (2005). Adverse cardiac effects associated with clozapine. Journal of Clinical Psychopharmacology 25, 32–41.
Newby, DE, Grubb, NR, Bradbury, A (2010). Cardiovascular disease. In Davidson’s Principles and Practice of Medicine 21st Edition (ed. N. R. Colledge, B. R. Walker and S. H. Ralston), pp. 521–640. Churchill Livingstone: Edinburgh.
Nissen, T, Wynn, R (2014). The clinical case report: a review of its merits and limitations. BMC Research Notes 7, 264.
Roh, S, Ahn, DH, Nam, JH, Yang, BH, Lee, BH, Kim, YS (2006). Cardiomyopathy associated with clozapine. Experimental and Clinical Psychopharmacology 14, 94–98.
Rostagno, C, Di Norscia, G, Placidi, GF, Gensini, GF (2008). Beta-blocker and angiotensin-converting enzyme inhibitor may limit certain cardiac adverse effects of clozapine. General Hospital Psychiatry 30, 280–283.
Sawicke, L, Sturla, S (2008). Potentially lethal cardiac side effects caused by psychiatric drugs. Vertex 19, 387–393.
Vaddadi, KS, Soosai, E, Vaddadi, G (2003). Low blood selenium concentrations in schizophrenic patients on clozapine. British Journal of Clinical Pharmacology 55, 307–309.
Wheeler, A, Hymerstone, V, Robinson, G (2009). Outcomes for schizophrenia patients with clozapine treatment: how good does it get? Journal of Psychopharmacology 23, 957–965.